Title of Collaborative Activity: |
COVID-19 Therapeutics Interagency Working Group |
Description of Collaborative Activity: |
To share updates on the wide range of COVID therapeutics efforts that are progressing across the agencies |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2020 |
NIH Participating Institutes/Centers/Office of the Director: |
NIAID |
HHS Agency Collaborators on this Activity: |
FDA, CDC |
